Following recent FDA and PMDA GLP audits, this achievement reaffirms that Medicilon’s preclinical research quality continues to meet the highest international standards.
Committed to Compliance Management, Empowering Global Drug Innovation
OECD GLP certification is recognized globally as the gold standard in preclinical safety evaluation for its rigor, comprehensiveness, and sustainability.
Operating under a “one-system, multi-country recognition” framework, Medicilon aligns laboratory operations with GLP requirements from:
China (NMPA)
U.S. (FDA)
Europe (EMA)
Australia (TGA)
South Korea (MFDS)
Building on NMPA, ICH, and FDA standards, we have established an advanced preclinical research platform supporting innovative therapies, including:
ADCs
PROTACs
Antibodies
Nucleic Acid Drugs
For more info, contact:
Email: [email protected] Tel: +44 1223981791
Global Headquarters: 585 Chuanda Road, Pudong, Shanghai, 201299, China
UK Office: Ailla Future Business Centre, King's Hedges Road Cambridge, CB4 2HY
